
Patients commonly reported unexplained blurred or hazy vision postoperatively that requires further investigation
Patients commonly reported unexplained blurred or hazy vision postoperatively that requires further investigation
Researchers conducted a study to characterize ophthalmic adverse events associated with cosmetics and personal care products that have been reported in the FDA CAERS database.
From cytokine pathways to genomics, Shree Kurup, MD, highlights new approaches for managing diabetic retinopathy and combating systemic inflammation.
Patients’ near visual needs is important when prescribing medications for glaucoma treatment
This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after 6 months of treatment in a retrospective chart review that included 102 patients with nAMD who had had suboptimal responses to other anti-VEGF therapies.
Real-world scenarios showcase a shift in treatment paradigms
This prospective case-control study included 85 patients with lung involvement related to the COVID-19 virus and a group of 50 healthy controls
Researchers reported identifying changes in 4 areas of the brain
Previous research has shown that voretigene neparvovec administered subretinally early in childhood for RPE65-mediated inherited retinal dystrophy achieved encouraging efficacious results.
The main outcomes were the measurements of the visual acuity and visual field defects.
Investigators examined the connection between amblyopia, components of the metabolic syndrome and individual cardiometabolic diseases.
Among these eyes, 18.9% of eyes developed nAMD within 36 months.
The investigators found that the premature births to be associated with vascular changes on ocular coherence tomography-angiography.
Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical characteristics of choroidal metastasis in this patient population and report treatment outcomes after targeted therapy compared with conventional radiotherapy and/or chemotherapy.
The “Triangle sign” seen on ultrasound is a “distinctive and reliable” ultrasound feature for differentiating total choroidal detachments and suprachoroidal hemorrhages.
Chen and colleagues conducted a longitudinal study that included patients with high myopia who were followed for 10 years. Detailed ophthalmic examinations were conducted at the baseline and follow-up visits that included measurements of the BCVA and visual fields in 568 eyes of 284 patients.
The NeurEYE research team will use millions of eye scans from Scottish optometrists to create the data set.
The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.
Changes can result in bacterial contamination, loss of drug activity, and inflammation
Following the switch from multifocal to single-vision contact lenses, axial elongation increased by 0.03 mm/year, and myopia progressed at a rate of −0.17 D annually after switching to single-vision lenses.
Cost among other factors may deter patients from screening, especially in rural and low-resource settings.
Study sees a positive association between the dietary inflammatory index (DII) and non-refractive visual impairment among US populations
These resources include downloadable fact sheets, glaucoma financial assistance resources, shareable social media graphics, and a dedicated webpage.
Patients with fibromyalgia experienced changes in the macular ganglion cell layer and retinal nerve fiber layer.
The multinational, multicenter, prospective RESTORE Study is the 5-year follow-up study of the phase 3 clinical RESCUE and REVERSE Studies of lenadogene nolparvovec to treat vision loss from LHON due to the MT-ND4 mutation.
The rationale was that commercial mydriatics administered during retinopathy of prematurity (ROP) screening have been associated with cardiorespiratory and gastrointestinal adverse events.
Investigators conducted a meta-analysis of randomized controlled trials to assess the efficacy and safety of brolucizumab compared with aflibercept in patients with DME.